 |
| [11] Publication Number: |
2147249 |
| [13] Kind of Document: |
C1 |
| [14] Publication Date: |
2000.04.10 |
| [19] Publishing Country or Organization: |
RU |
| [21] Appl. No.: |
97100800/14 |
| [22] Filled: |
1997.01.20 |
| [24] Effective Dates for Priority rights: |
1997.01.20 |
| [46] Claim(s) date: |
2000.04.10 |
| [51] Int. Cl.: |
A61N5/06 |
| [71] Applicant: |
Butenin A.V., Vorozhtsov G.N., Kalija O.L., Kogan B.Ja.,
Kogan E.A., Kopranenkov V.N., Loshchenov V.B., Luk'janets
E.A., Meerovich G.A., Torshina N.L., Kharnas S.S. |
| [75] Inventors: |
Butenin A.V., Vorozhtsov G.N., Kalija O.L., Kogan B.Ja.,
Kogan E.A., Kopranenkov V.N., Loshchenov V.B., Luk'janets
E.A., Meerovich G.A., Torshina N.L., Kharnas S.S. |
| [73] Assignee: |
Butenin A.V., Vorozhtsov G.N., Kalija O.L., Kogan B.Ja.,
Kogan E.A., Kopranenkov V.N., Loshchenov V.B., Luk'janets
E.A., Meerovich G.A., Torshina N.L., Kharnas S.S. |
[57] Abstract:
|
FIELD: medicine. SUBSTANCE: method
involves introducing photosensibilizer. The pathogenic area is irradiated
with optic radiation which wavelength belongs to spectral bandwidth
of the photosensibilizer. Ascorbic acid is administered or alkaline
metalascorbates not less than 0.5 h before exposure at a dose of
not less than 5 mg/kg of patient body weight. EFFECT: enhanced effectiveness
of treatment course; reduced frequency of recidivation and process
generalization. 6 cl
|
 Top
|
Back
Home
Mail